RedixFi
Pre-openNIFTY24,536.6+2.4%
Market feed live

SIGACHI · Sigachi Industries Ltd · Chemical Manufacturing

SIGACHI · Sigachi Industries Ltd · Chemical Manufacturing

₹27.82-1.0%

As of 05 Nov close

52-week range

52wk low ₹16.6552wk high ₹40.8

31.8% below 52-week high

52-week range: as of 05 Nov 2026 close.

Price chartDaily closes on the stock page.

Stock Condition:Pro

Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.

Full signal detail →

Fundamentals as of 15 Sep 2026 · the company's own latest record is 52 days old

Operating margin above its own averageFII holding falling for 2+ quarters

Revenue (latest Q)

₹121 Cr

Revenue YoY

PAT YoY

+106.7%

Operating margin

Revenue, last 8 quarters

P/E (TTM)

P/B

2.6

P/S (TTM)

3.1

Sector P/E

36.3

Dividend yield

+0.3%

CompanyP/EP/BNet marginROED/EDiv. yield
SIGACHI (this stock)35.52.6+5.4%+4.9%0.31+0.3%
Asian Paints5311.1+12.8%+22.3%0.18+1.1%
Solar Industries India99.626.6+17.6%+31.4%13.68+0.1%
Pidilite Industries61.319.4+17.2%+24.4%0.04+0.7%

Promoter

stable

FII

falling 2q

MF

Not available from data source

Insider trades

No insider trades in the last 12 months.

Bulk/block deals

datecanonicalSymbolbuy quantitybuyer countdeal strengthdeal types present
2026-09-18SIGACHI00STRONGBULK

News timeline

No related news.

Concalls & investor presentations

AI-generated
Concall transcriptNeutral20 Aug 2026
View source filing →

Key takeaway: Sigachi Industries Limited reported Q1 FY27 results with total operating income of INR121.27 crores, EBITDA of INR16.5 crores (13.6% margin), and net profit of INR8.14 crores (6.76% margin). The MCC segment contributed INR82.74 crores, while O&M and API segments generated INR13.06 crores and INR21.68 crores, respectively. Management highlighted stable operations, with 76.8% overall capacity utilization and a Dahej-2 expansion (12,000 metric tons) progressing for completion by Q2 FY28, which will increase total cellulose-based excipient capacity to 30,000 metric tons. The company launched HiCel SMCC Nutra, a differentiated excipient targeting nutraceutical applications. MCC realization increased to INR241.36 per kg from INR216 per kg in the previous quarter. Management noted strong demand for MCC, driven by quality and regulatory compliance, though capacity expansion by competitors is a concern. API revenue is expected to grow, with new molecules like Sparsentan and Bempedoic Acid contributing higher margins. The company is targeting INR650-675 crores in revenue for FY27, with EBITDA margins aiming for 18%. Capex for FY27 is expected to be over INR100 crores, with additional spending planned for FY28. Insurance claims from a prior incident are expected to be resolved by September, with potential delays in capex funding if unresolved. The CCS segment, relying on imported CMC from China, is expected to have healthier margins (25%+) and is primarily export-focused. Management emphasized disciplined execution, capacity expansion, and product diversification as key priorities for long-term growth.

The summary presents factual results, operational updates, and management commentary without overtly positive or negative language.

Sourced from an exchange-filed transcript, dated 20 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.

Investor presentationMixed13 Aug 2026
View source filing →

Key takeaway: The investor presentation for Q1 FY 2026-27 from Sigachi Industries Limited outlined the company's operational and financial highlights, emphasizing its commitment to growth and innovation. Management reported steady progress in capacity expansion at Dahej, which aims to enhance manufacturing capabilities. The presentation highlighted a global presence with over 500 customers across 65 countries and a diverse product range exceeding 100 offerings. Financially, the company reported a revenue from operations of Rs. 1,213 million, a decrease of 5.38% year-over-year, with a PAT of Rs. 82 million. The EBITDA margin was noted at 13.60%, reflecting a decline from the previous year. Management underscored a focus on operational efficiency and sustainable value creation, alongside ongoing investments in research and development to support future growth.

The presentation conveyed both achievements and challenges in financial performance.

Sourced from an exchange-filed presentation, dated 13 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.

Concall transcriptNeutral05 Jun 2026
View source filing →

Key takeaway: Sigachi Industries Limited held its Q4 FY26 Earnings Conference Call on May 30, 2026, where management discussed the company's performance and future plans. Managing Director Amit Raj Sinha highlighted that FY26 was a year of challenges and decisive actions, focusing on operational discipline and sustainable growth. The company reported stable operations with cellulose-based excipient sales of 14,857 metric tons and an 82% capacity utilization. CFO O.S. Reddy provided financial highlights, noting total operating income of INR 121.89 crores and a net profit of INR 7.6 crores for the quarter. Management set a revenue guidance for FY27 in the range of INR 650-675 crores, supported by new capacities and an improved product mix. The call also addressed ongoing projects, including a 12,000 metric tons capacity expansion at Dahej, and the anticipated commercialization of a CCS facility in Q1 FY28. Management expressed confidence in returning to pre-incident margin levels by mid-FY28.

The management provided a balanced overview of past challenges and future plans without strong emphasis on either positive or negative aspects.

Sourced from an exchange-filed transcript, dated 05 Jun 2026. Summary is RedixFi-generated and distinct from investment advice.

Investor presentationMixed30 May 2026
View source filing →

Key takeaway: The investor presentation for Q4 FY 2025-26 from Sigachi Industries Limited outlined the company's operational and financial highlights, emphasizing a year of resilience and strategic growth. Management reported that the Dahej-2 capacity expansion is on schedule, aiming to elevate total MCC capacity to 30,000 MTPA. The presentation highlighted a global customer base of over 500 across 65 countries and noted a 19.92% revenue CAGR over five years. Financially, the company reported a revenue of Rs. 1,219 million for Q4 FY26, a 4.01% increase QoQ, but a 4.91% decrease YoY. EBITDA margin was reported at 12.63%, down from 22.31% YoY. Management set a goal for FY27 to achieve revenue between Rs. 6,500 - 6,750 million and an EBITDA margin of 18% - 20%. The presentation also emphasized the company's commitment to sustainability and community engagement through CSR initiatives.

The presentation highlighted both challenges and strategic growth initiatives.

Sourced from an exchange-filed presentation, dated 30 May 2026. Summary is RedixFi-generated and distinct from investment advice.

Concall transcriptMixed20 Feb 2026
View source filing →

Key takeaway: Sigachi Industries Limited held its Q3 FY26 earnings conference call on February 14, 2026, where management provided updates on operational and financial performance. Managing Director Amit Raj Sinha reported that the company focused on rebuilding with stronger systems and accountability, ensuring operational stability despite challenges from a recent fire incident at the Hyderabad facility. The current cellulose-based excipient capacity is 18,000 metric tons per annum, with plans for expansion to 30,000 metric tons by Q3 FY27. CFO O.S. Reddy reported total operating income of INR 117.2 crores and an EBITDA margin of 4.6% for the quarter, attributing lower margins to increased transportation costs and overheads due to the fire. Management indicated that production constraints impacted revenue, but demand remained strong. The company anticipates a gradual return to normalcy in operations and margins as expansion projects progress.

Management highlighted both operational challenges and ongoing growth initiatives.

Sourced from an exchange-filed transcript, dated 20 Feb 2026. Summary is RedixFi-generated and distinct from investment advice.

Investor presentationMixed14 Feb 2026
View source filing →

Key takeaway: The investor presentation for Q3 FY 2025-26 from Sigachi Industries Limited detailed the company's operational and financial highlights, emphasizing a commitment to stability and growth. Management reported that the company is operating at planned capacity with stable supply chains and strong customer demand. The presentation highlighted a 5-year revenue CAGR of 29% and an EBITDA CAGR of 35%. However, the financial results for Q3 FY26 showed a revenue decline of 15.92% year-over-year, with a significant drop in EBITDA by 82.83%. The document also outlined the company's focus on sustainability and corporate social responsibility, noting that over 12,600 lives were impacted through CSR initiatives. Management reiterated their commitment to operational excellence and innovation, with ongoing investments in R&D and expansion plans for manufacturing capacity.

The presentation conveyed both achievements and challenges in financial performance.

Sourced from an exchange-filed presentation, dated 14 Feb 2026. Summary is RedixFi-generated and distinct from investment advice.

AI Summary of Annual Report

AI-generated
FY2025-26285 pages

Sigachi Industries Limited's FY2025-26 annual report highlights the company's strategic positioning in the global microcrystalline cellulose (MCC) market, which is projected to grow at a compound annual rate of 6-7% over the next decade. The report emphasizes India's growing pharmaceutical industry, valued at USD 42 billion and management expects it to reach USD 80 billion by 2033, as a key growth driver. Sigachi is expanding its manufacturing capacity and focusing on governance, sustainability, and diversification to capitalize on long-term demand in pharmaceutical excipients and nutraceuticals. The company also outlines challenges related to production costs, regulatory compliance, and raw material volatility.

  • Sigachi is expanding manufacturing capacity to meet growing demand in the global MCC market, projected to grow at 6-7% CAGR.
  • Management expects India's pharmaceutical industry to grow to USD 80 billion by 2033, providing a favorable market environment for Sigachi.
  • The company is focusing on governance, sustainability, and diversification to strengthen its position in pharmaceutical excipients and nutraceuticals.
  • Sigachi is investing in capacity expansion at Dahej SEZ to achieve economies of scale and secure tax benefits for export-oriented growth.

Key takeaway: Sigachi Industries is strategically expanding its manufacturing capacity and focusing on governance and sustainability to capitalize on long-term growth in the pharmaceutical excipients and nutraceuticals markets.

The following annual report excerpts provide qualitative strategic context. Do not treat any specific financial figures in these excerpts as authoritative — they may be incorrectly labeled due to PDF table extraction limitations. For precise financial data, refer to the structured fundamentals data above.

Filed with NSE · 07 Sept 2026View source filing →

Governance disclosures

AI-generated

Needs attention

Regulatory Action (2 items); Default / Covenant Breach (1 item)

Items of these kinds are disclosed in the filings. This is a count of disclosed items. It is not a finding about the company and its cause has not been independently established.

Regulatory Action

2 occurrences

Earlier (1-3 years ago)

Annual Report01 Sept 2025 (FY2024-25)· 2 passages
View source filing →

Sigachi Industries Limited faced a regulatory action by BSE and NSE in FY 2022-23 under SEBI LODR 17(1A) regarding non-compliance with requirements for the appointment or continuation of Mr. Swami Das Nigam.

Annual Report13 Aug 2024 (FY2023-24)
View source filing →

The company was fined by BSE and NSE for non-compliance with SEBI LODR regulations regarding the appointment of a non-executive director who had reached the age of seventy-five years.

Default / Covenant Breach

1 occurrence

Earlier (1-3 years ago)

Annual Report01 Sept 2025 (FY2024-25)
View source filing →

Sigachi Industries Limited has statutory dues in arrears as of March 31, 2025, for more than six months, including a service tax and penalty dispute amounting to ₹5.59 crore (penalty ₹2.50 crore) pending at the Appellate Tribunal Regional Bench Hyderabad relating to the period August 2014 to June 2017.

Routine disclosures

Contingent Liability

3 occurrences

Recent (last 12 months)

Annual Report07 Sept 2026 (FY2025-26)· 2 passages
View source filing →

The company has a contingent liability related to a service tax demand notice received during the year ended 31 March 2020.

Earlier (1-3 years ago)

Annual Report01 Sept 2025 (FY2024-25)· 2 passages
View source filing →

The company has a contingent liability related to a service tax demand notice for the period August 2014 to June 2017, amounting to ₹5,59,20,813 (including a penalty of ₹2,50,47,324).

Annual Report13 Aug 2024 (FY2023-24)
View source filing →

The company received a demand notice from the commissioner of central tax (Service tax) for Rs. 5,59,20,813/- (including penalty of Rs.2,50,47,324/-) for the period August 2014 to June 2017. The company has filed appeals against this notice, which are pending disposal.

Related-Party Transaction

3 occurrences

Recent (last 12 months)

Annual Report07 Sept 2026 (FY2025-26)· 4 passages
View source filing →

The company has advanced Rs 16.30 Crores to Trimax Bio Sciences Private Limited, a material subsidiary with common directors, indicating a related-party transaction.

Earlier (1-3 years ago)

Annual Report01 Sept 2025 (FY2024-25)· 4 passages
View source filing →

The company approved a one-time material related party transaction to make investment and convert loan/advances into equity of M/s. Trimax Bio Sciences Private Limited, a subsidiary.

Annual Report13 Aug 2024 (FY2023-24)· 2 passages
View source filing →

The company had a one day delay in submission of audio recordings of the investor meet on 20.01.2024 and Related party transactions for the Quarter ended 30.09.2023 under SEBI LODR Regulations to the Stock Exchanges and the Company remitted the penalty levied by the Exchanges.

Statutory dues in dispute

1 occurrence

Earlier (1-3 years ago)

Annual Report13 Aug 2024 (FY2023-24)Disputed tax/statutory dues under appeal, not a loan default
View source filing →

The company has a pending dispute related to Service Tax and Penalty under the Service Tax Act for the period August 2014 to June 2017, with an amount of 5.59 crore (including a penalty of 2.50 crore). The dispute is pending at the Service Tax & Penalty forum.

Management & Board Governance

1 occurrence

Earlier (1-3 years ago)

Annual Report01 Sept 2025 (FY2024-25)· 2 passages
View source filing →

Mr. Sarweswara Reddy Sanivarapu resigned as Chairman w.e.f 30.11.2024, and Mr. Janardhana Reddy Yeddula was appointed as Chairman w.e.f 30.11.2024.

Promoter Share Pledge

1 occurrence

Recent (last 12 months)

Structured Filing Data (NSE Pledge Disclosure)18 Jul 2026

10.95% of promoter holding pledged (quarter 2026-Q3 as of 2026-07-18). Change vs the previous disclosure: decreasing.

Open full Signal Dashboard →